Innate Pharma SA Noncurrent Financial Liabilities
Innate Pharma SA (IPHA) had Noncurrent Financial Liabilities of EUR 13.77 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:NoncurrentFinancialLiabilities · last filed 2026-04-01
- 2025-12-31: Noncurrent Financial Liabilities 13.77M EUR.
- 2025-06-30: Noncurrent Financial Liabilities 18.09M EUR.
- 2024-12-31: Noncurrent Financial Liabilities 22.29M EUR.
- 2024-06-30: Noncurrent Financial Liabilities 26.57M EUR.
| Period end | Noncurrent Financial Liabilities | Noncurrent Financial Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 13.77M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 18.09M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 22.29M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 26.57M EUR 6-K · filed 2024-09-12 | |
| 2023-12-31 | 30.96M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 35.32M EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 40.15M EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 12.52M EUR 6-K · filed 2022-09-15 | |
| 2021-12-31 | 13.50M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 14.48M EUR 6-K · filed 2021-09-15 | |
| 2020-12-31 | 16.95M EUR 20-F · filed 2023-04-06 | |
| 2019-12-31 | 16.59M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 3.17M EUR 20-F · filed 2021-04-27 | 3.17M EUR 20-F · filed 2020-04-24 |
| 2017-12-31 | 4.52M EUR 20-F · filed 2020-04-24 |